6/30/24 6/30/24 Laboratory Tests for Neonatal Sepsis: Improving Diagnosis and Treatment Read More 6/22/24 6/22/24 Laboratory Testing for Neonatal Jaundice in the United States - Key Markers and Importance Read More 6/8/24 6/8/24 The Critical Role of Medical Laboratories in Monitoring aPTT Levels for Patients on Anticoagulant Therapy Read More 6/7/24 6/7/24 Anticoagulant Therapy Monitoring Tests: Process, Role of Phlebotomists, and Challenges Read More 6/20/24 6/20/24 Anticoagulant Medications: Common Types and Monitoring Requirements Read More 6/2/24 6/2/24 Anticoagulant Therapy Monitoring Tests in the United States: PT/INR, aPTT, and Anti-Xa - Overview and Importance Read More 6/16/24 6/16/24 Anticoagulant Medications: Monitoring Requirements and Strategies Read More 6/23/24 6/23/24 Common Anticoagulant Medications in the United States: Warfarin, Heparin, Rivaroxaban, and Apixaban Read More 6/12/24 6/12/24 Laboratory Procedures and Tests for Factor V Leiden Mutation Read More 6/2/24 6/2/24 Understanding Factors Contributing to Prolonged Prothrombin Time (PT) Results: Implications for Diagnosis and Treatment Read More 6/6/24 6/6/24 Understanding PT and aPTT in Medical Laboratories: Key Differences, Procedures, and Indications Read More 6/10/24 6/10/24 Understanding the Normal Reference Ranges for Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT) in the United States Read More 6/27/24 6/27/24 Understanding the Normal Range for PT and APTT Results: Key Factors and Importance Read More 6/19/24 6/19/24 Monitoring PT and APTT Levels for Common Clotting Disorders in the United States Read More 6/5/24 6/5/24 Assessing Coagulation Status: Understanding Normal Ranges for PT and aPTT in Adults Read More 6/21/24 6/21/24 Assessing Blood Clotting Function: PT and aPTT Testing Protocols in the United States Read More 6/26/24 6/26/24 Understanding the Importance of Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT) Tests Read More 6/25/24 6/25/24 Understanding the Clinical Significance of Abnormal PT and aPTT Results Read More 6/5/24 6/5/24 Understanding Normal Reference Ranges for PT and aPTT in Coagulation Disorders Read More 6/11/24 6/11/24 Normal Reference Ranges for Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT) in the United States Read More Older Posts
6/22/24 6/22/24 Laboratory Testing for Neonatal Jaundice in the United States - Key Markers and Importance Read More
6/8/24 6/8/24 The Critical Role of Medical Laboratories in Monitoring aPTT Levels for Patients on Anticoagulant Therapy Read More
6/7/24 6/7/24 Anticoagulant Therapy Monitoring Tests: Process, Role of Phlebotomists, and Challenges Read More
6/2/24 6/2/24 Anticoagulant Therapy Monitoring Tests in the United States: PT/INR, aPTT, and Anti-Xa - Overview and Importance Read More
6/23/24 6/23/24 Common Anticoagulant Medications in the United States: Warfarin, Heparin, Rivaroxaban, and Apixaban Read More
6/2/24 6/2/24 Understanding Factors Contributing to Prolonged Prothrombin Time (PT) Results: Implications for Diagnosis and Treatment Read More
6/6/24 6/6/24 Understanding PT and aPTT in Medical Laboratories: Key Differences, Procedures, and Indications Read More
6/10/24 6/10/24 Understanding the Normal Reference Ranges for Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT) in the United States Read More
6/27/24 6/27/24 Understanding the Normal Range for PT and APTT Results: Key Factors and Importance Read More
6/19/24 6/19/24 Monitoring PT and APTT Levels for Common Clotting Disorders in the United States Read More
6/5/24 6/5/24 Assessing Coagulation Status: Understanding Normal Ranges for PT and aPTT in Adults Read More
6/21/24 6/21/24 Assessing Blood Clotting Function: PT and aPTT Testing Protocols in the United States Read More
6/26/24 6/26/24 Understanding the Importance of Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT) Tests Read More
6/5/24 6/5/24 Understanding Normal Reference Ranges for PT and aPTT in Coagulation Disorders Read More
6/11/24 6/11/24 Normal Reference Ranges for Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT) in the United States Read More
